Sign In
Buy ZTS
$77.59
+1.20 (+1.57%)
At Close: Jun 03, 2026
Zoetis Remains A Strong Buy Following Market Overreaction To Q3 Earnings
09:36am, Thursday, 06'th Nov 2025
Zoetis Inc. is trading at historically low valuations despite continued EPS and margin growth, following a sharp post-earnings selloff. ZTS's Q3 results showed resilient profitability, but weaker guid
Diamond Hill Capital's Strategic Moves: A Closer Look at Zoetis Inc.
06:00pm, Wednesday, 05'th Nov 2025
Exploring Diamond Hill Capital (Trades, Portfolio)'s Latest 13F Filing for Q3 2025
Diamond Hill Capital (Trades, Portfolio) recently submitted its 13F filing f
Zoetis Inc. (ZTS) Q3 2025 Earnings Call Transcript
04:16pm, Tuesday, 04'th Nov 2025
Zoetis Inc. ( ZTS ) Q3 2025 Earnings Call November 4, 2025 8:30 AM EST Company Participants Steven Frank - Vice President of Investor Relations Kristin Peck - CEO & Director Wetteny Joseph - Executive
Zoetis Stock Outlook Clouded By Rising Competitive Pressures
01:15pm, Tuesday, 04'th Nov 2025
Animal health firm Zoetis Inc. (NYSE:ZTS) on Tuesday reported a third-quarter 2025 adjusted earnings per share of $1.70.
ZTS Q3 Earnings Beat, Revenues Miss, '25 Sales View Cut, Stock Down
12:46pm, Tuesday, 04'th Nov 2025
Zoetis tops Q3 earnings forecasts but misses on revenues and trims 2025 sales outlook, sending shares lower on weak U.S. results.
Zoetis: No Longer A Growth Stock
12:41pm, Tuesday, 04'th Nov 2025
Zoetis shares have underperformed, falling over 25% in the past year, with recent guidance disappointing investors. Organic growth is slowing, especially in the United States, as core products reach m
Compared to Estimates, Zoetis (ZTS) Q3 Earnings: A Look at Key Metrics
10:30am, Tuesday, 04'th Nov 2025
The headline numbers for Zoetis (ZTS) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estima
Zoetis (ZTS) Surpasses Q3 Earnings Estimates
09:11am, Tuesday, 04'th Nov 2025
Zoetis (ZTS) came out with quarterly earnings of $1.7 per share, beating the Zacks Consensus Estimate of $1.62 per share. This compares to earnings of $1.58 per share a year ago.
This Animal Health Stock Tanks on Earnings. Pig and Chicken Medication Revenue Slumps.
08:59am, Tuesday, 04'th Nov 2025
Zoetis slashes its full-year outlook.
Zoetis Stock Crumbles After Slashing 2025 Sales Outlook
08:23am, Tuesday, 04'th Nov 2025
The animal health company now expects just $9.4 billion-$9.475 billion in sales for the year. Zoetis stock tumbled.
Zoetis Inc (ZTS) Q3 2025 Earnings: EPS of $1.63 Beats Estimates, Revenue at $2.4 Billion Slightly Misses Expectations
07:31am, Tuesday, 04'th Nov 2025
Revenue: $2.4 billion, slightly below the estimated $2.410 billion, marking a 1% increase year-over-year.Earnings Per Share (EPS): Reported at $1.63, surpassin
Zoetis Announces Third Quarter 2025 Results
07:00am, Tuesday, 04'th Nov 2025
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) today reported its financial results for the third quarter of 2025. The company reported revenue of $2.4 billion for th
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE: ZTS) today announced that following a 10-year distinguished career dedicated to advancing veterinary medicine and innovatio
Zoetis: High-Quality Compounder For Patient Long-Term Dividend Growth Investors
09:30am, Monday, 03'rd Nov 2025
Zoetis is a US-based company involved in the discovery, development, manufacture, and marketing of animal medicines and vaccines. ZTS has increased its dividend for 13 consecutive years. This streak
2 Magnificent Dividend Stocks to Buy and Hold Forever
09:15am, Sunday, 02'nd Nov 2025
Investing in strong dividend stocks is a great way to earn better-than-average long-term returns. AbbVie has a reliable, non-cyclical business and a long and impressive track record of dividend growth
